Karyopharm Therapeutics Cash from Operations (TTM) Insights

Karyopharm Therapeutics Inc (KPTI)

1.165 -0.11 (-8.63%) USD | NASDAQ | Apr 19, 16:00

1.165 0.00 (0.00%) After-Hours: 17:39

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	-92.72M
September 30, 2023	-100.98M
June 30, 2023	-99.82M
March 31, 2023	-109.27M
December 31, 2022	-149.55M
September 30, 2022	-97.24M
June 30, 2022	-92.82M
March 31, 2022	-113.42M
December 31, 2021	-107.12M
September 30, 2021	-163.22M
June 30, 2021	-183.58M
March 31, 2021	-168.11M
December 31, 2020	-160.23M
September 30, 2020	-169.09M
June 30, 2020	-161.28M
March 31, 2020	-169.21M
December 31, 2019	-190.82M
September 30, 2019	-199.50M
June 30, 2019	-201.66M
March 31, 2019	-191.09M
December 31, 2018	-159.12M

Date	Value
September 30, 2018	-116.48M
June 30, 2018	-99.57M
March 31, 2018	-83.66M
December 31, 2017	-73.72M
September 30, 2017	-88.18M
June 30, 2017	-86.76M
March 31, 2017	-85.93M
December 31, 2016	-84.39M
September 30, 2016	-84.77M
June 30, 2016	-89.76M
March 31, 2016	-96.97M
December 31, 2015	-94.03M
September 30, 2015	-86.42M
June 30, 2015	-77.32M
March 31, 2015	-61.10M
December 31, 2014	-51.45M
September 30, 2014	-48.76M
June 30, 2014	-41.43M
March 31, 2014	-35.70M
December 31, 2013	-30.29M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-201.66M

Minimum

Jun 2019

-92.72M

Maximum

Dec 2023

-143.67M

Average

-160.23M

Median

Dec 2020

Cash from Operations (TTM) Benchmarks